Patient-reported neuropathy and taxane-associated symptoms in a phase 3 trial of nab-paclitaxel plus carboplatin versus solvent-based paclitaxel plus carboplatin for advanced non-small-cell lung cancer
Vera Hirsh, Isamu Okamoto, Jeremy K. Hon, Ray D. Page, James Orsini, Hiroshi Sakai, Hui Zhang, Markus F. Renschler, Mark A. Socinski
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Patient-reported neuropathy and taxane-associated symptoms in a phase 3 trial of nab-paclitaxel plus carboplatin versus solvent-based paclitaxel plus carboplatin for advanced non-small-cell lung cancer'. Together they form a unique fingerprint.